rss
Pract Neurol 2005;5:46-51 doi:10.1111/j.1474-7766.2005.00276.x
  • Neurological Rarity

Wound Botulism

  1. Katarzyna A. Sieradzan
  1. Consultant Neurologist, Institute of Clinical Neurosciences, Frenchay Hospital, Bristol, BS16 1LE, Tel. 0117 9186603; E-mail: KSieradzan{at}aol.com

      Abstract

      INTRODUCTION

      Wound botulism used to be a rare form of a rare disease but recent outbreaks among injecting drug users in the USA and UK have changed this epidemiological pattern. Three years ago when I saw my first patient it was very unfamiliar territory. But once seen, never forgotten. When some months ago I was asked to see a patient in the Intensive Therapy Unit (ITU), a known drug user, who had collapsed with respiratory failure, the history sounded unmistakable and I had little doubt what the diagnosis would be. This was the fourth case in an injecting drug user seen in our centre over the last three years.

      BOTULISM

      Botulism is caused by the spore-forming strict anaerobic bacterium, Clostridium botulinum, found in soil and aquatic sediments. It produces the most potent neurotoxin known in nature. Botulinum toxin spreads systemically and binds irreversibly to the presynaptic portion of cholinergic synapses

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

      Latest neurology and neurosurgery jobs

      Latest neurology and neurosurgery jobs